Envoy Medical announces it has been awarded another patent from the US Patent & Trademark Office for its fully implanted devices. On September 3rd, the Company was issued Patent No. 12,081,061, “Recharge System for Implantable Battery,” which relates to predicting a cumulative thermal dose associated with charging an implantable rechargeable energy storage device to a fully charged state and adjusting the amount of current provided to the device during charging. In other words, this can be used to maintain a safe temperature of an implanted rechargeable battery during recharging.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COCH:
- Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
- Envoy Medical secures lending facility of $10M
- Envoy Medical reports Q2 EPS (27c), consensus (25c)
- Envoy Medical announces support for new bipartisan Senate bill
- Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage